Please check your internet connection and try again.
# Hepamerz (l-Ornithine l-Aspartate)
## Overview
Hepamerz is a combination of the amino acids l-ornithine and l-aspartate. It is believed to reduce ammonia levels in the blood by promoting its detoxification in the liver and kidneys.
## Primary Indications
Treatment of latent and manifest hepatic encephalopathy (HE) in patients with liver disease.
## Adult Dosing
* **Oral:** 3 to 6 grams three times daily, taken with or after meals. The total daily dose should not exceed 18 grams.
* **Intravenous:** 5 grams to 10 grams once or twice daily, infused over 30-60 minutes. In acute HE, doses up to 25 grams per day have been used, but the optimal dosage and duration are not well-established.
## Pediatric Dosing
* The use of l-ornithine l-aspartate in pediatric patients is not well-established. Dosing recommendations are not available.
## Dose Adjustments
No specific dose adjustments are typically recommended for renal or hepatic impairment, as the drug is intended for patients with liver dysfunction. However, caution is advised in patients with significant renal impairment due to potential accumulation of the amino acids.
## Contraindications
* Hypersensitivity to l-ornithine l-aspartate or any component of the formulation.
* Severe renal failure (creatinine clearance < 30 mL/min).
## Adverse Effects
The most common adverse effects include gastrointestinal disturbances such as nausea, vomiting, and diarrhea. Headache and dizziness have also been reported.
## Key Drug Interactions
No significant drug interactions are reported.
## Monitoring
* Monitor ammonia levels, especially in patients not responding to treatment or showing worsening encephalopathy.
* Assess for gastrointestinal side effects.
* Monitor renal function in patients with impaired kidney function.
## Clinical Pearls
* The efficacy and optimal duration of treatment for HE are debated, and l-ornithine l-aspartate is often used as an adjunct to other management strategies.
* For oral administration, it is best taken with or after meals to minimize gastrointestinal upset.
* Intravenous administration should be done slowly to avoid local irritation and potential adverse effects.
***
*Disclaimer: This information is intended for clinical professionals. Always consult the most current prescribing information and local protocols for definitive guidance.*
